A Rare Case Report: Carcinoma Pancreas with Hepatocellular Carcinoma

被引：1

作者：

Yadav, Vikas ^{[1
]}

Panda, Dipanjan ^{[2
]}

Patidar, Yashwant ^{[3
]}

Bihari, Chhagan ^{[4
]}

机构：

[1] Inst Liver & Biliary Sci, Dept Radiat Oncol, New Delhi, India

[2] Inst Liver & Biliary Sci, Dept Med Oncol, New Delhi, India

[3] Inst Liver & Biliary Sci, Dept Radiol, New Delhi, India

[4] Inst Liver & Biliary Sci, Dept Pathol, New Delhi, India

来源：

INDIAN JOURNAL OF PALLIATIVE CARE | 2014年 / 20卷 / 01期

关键词：

Hepatocellular carcinoma; Pancreatic carcinoma; Synchronous double malignancy;

D O I：

10.4103/0973-1075.125562

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Synchronous double malignancies involving different organs are relatively rare and uncommon finding. We report an interesting case of double malignancy in which a patient exhibited synchronous two separate carcinomas, pancreatic and hepatocellular carcinoma (HCC). Patient was a 64-year-old male who presented primarily with symptoms pertaining to the biliary obstruction and ultrasound of abdomen revealing pancreatic head mass. HCC was detected incidentally during the investigations for carcinoma pancreas.

引用

页码：53 / 56

页数：4

共 16 条

[1] Current standards of surgery for pancreatic cancer [J].

Alexakis, N ;

Halloran, C ;

Raraty, M ;

Ghaneh, P ;

Sutton, R ;

Neoptolemos, JP .

BRITISH JOURNAL OF SURGERY, 2004, 91 (11) :1410-1427

[2] Screening for hepatocellular carcinoma in cirrhosis [J].

Bolondi, L .

JOURNAL OF HEPATOLOGY, 2003, 39 (06) :1076-1084

[3] Multiple primary malignant neoplasms - Case report and a comprehensive review of the literature [J].

Demandante, CGN ;

Troyer, DA ;

Miles, TP .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (01) :79-83

[4] Synchronous or metachronous double cancers of the pancreas and other organs: Report on 12 cases [J].

Eriguchi, N ;

Aoyagi, S ;

Hara, M ;

Okuda, K ;

Tamae, T ;

Fukuda, S ;

Hashino, K ;

Sato, S ;

Fujiki, K ;

Furukawa, S ;

Jimi, A .

SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 2000, 30 (08) :718-721

[5]

Eriguchi Naofumi, 2000, Kurume Medical Journal, V47, P169

[6] A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma [J].

Fuchs, CS ;

Clark, JW ;

Ryan, DP ;

Kulke, MH ;

Kim, H ;

Earle, CC ;

Vincitore, M ;

Mayer, RJ ;

Stuart, KE .

CANCER, 2002, 94 (12) :3186-3191

[7] Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma [J].

Guan, Z ;

Wang, Y ;

Maoleekoonpairoj, S ;

Chen, Z ;

Kim, WS ;

Ratanatharathorn, V ;

Reece, WHH ;

Kim, TW ;

Lehnert, M .

BRITISH JOURNAL OF CANCER, 2003, 89 (10) :1865-1869

[8] Cancer statistics, 2006 [J].

Jemal, A ;

Siegel, R ;

Ward, E ;

Murray, T ;

Xu, JQ ;

Smigal, C ;

Thun, MJ .

CA-A CANCER JOURNAL FOR CLINICIANS, 2006, 56 (02) :106-130

[9]

Kasumi F, 1977, JPN J CANC CLIN, V23, P1306

[10] Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation [J].

Llovet, JM ;

Fuster, J ;

Bruix, J .

HEPATOLOGY, 1999, 30 (06) :1434-1440

← 1 2 →